Sara Rinne
Postdoktor vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerprecisionsmedicin; Forskargrupp Marika Nestor
- E-post:
- sara.rinne@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA

Publikationer
Urval av publikationer
-
Ingår i Scientific Reports, 2021
- DOI för Ga-66-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [Ga-66]Ga-NOTA-PEG(2)-RM26
- Ladda ner fulltext (pdf) av Ga-66-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [Ga-66]Ga-NOTA-PEG(2)-RM26
-
Ingår i International Journal of Molecular Sciences, 2020
- DOI för Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules
- Ladda ner fulltext (pdf) av Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules
-
Ingår i International Journal of Molecular Sciences, 2020
- DOI för Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules
- Ladda ner fulltext (pdf) av Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules
-
Ingår i Scientific Reports, 2019
- DOI för Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111
- Ladda ner fulltext (pdf) av Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111
-
Ingår i Cells, 2018
- DOI för Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs
- Ladda ner fulltext (pdf) av Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs
-
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017
Senaste publikationer
-
Pretargeted 177Lu/225Ac combination therapy of colorectal cancer
Ingår i Theranostics, s. 5898-5910, 2026
- DOI för Pretargeted 177Lu/225Ac combination therapy of colorectal cancer
- Ladda ner fulltext (pdf) av Pretargeted 177Lu/225Ac combination therapy of colorectal cancer
-
Ingår i ACS Pharmacology & Translational Science, s. 3872-3885, 2025
- DOI för Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents
- Ladda ner fulltext (pdf) av Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents
-
Ingår i ACS Pharmacology & Translational Science, s. 3228-3240, 2024
- DOI för Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts
- Ladda ner fulltext (pdf) av Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts
-
Ingår i Molecular Medicine Reports, 2024
- DOI för Reduction of renal activity retention of radiolabeled albumin binding domain-derived affinity proteins using a non-residualizing label strategy compared with a cleavable glycine-leucine-glycine-lysine-linker
- Ladda ner fulltext (pdf) av Reduction of renal activity retention of radiolabeled albumin binding domain-derived affinity proteins using a non-residualizing label strategy compared with a cleavable glycine-leucine-glycine-lysine-linker
-
Ingår i Cancers, 2023
- DOI för Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [Ga-68]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation
- Ladda ner fulltext (pdf) av Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [Ga-68]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation
Alla publikationer
Artiklar i tidskrift
-
Pretargeted 177Lu/225Ac combination therapy of colorectal cancer
Ingår i Theranostics, s. 5898-5910, 2026
- DOI för Pretargeted 177Lu/225Ac combination therapy of colorectal cancer
- Ladda ner fulltext (pdf) av Pretargeted 177Lu/225Ac combination therapy of colorectal cancer
-
Ingår i ACS Pharmacology & Translational Science, s. 3872-3885, 2025
- DOI för Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents
- Ladda ner fulltext (pdf) av Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents
-
Ingår i ACS Pharmacology & Translational Science, s. 3228-3240, 2024
- DOI för Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts
- Ladda ner fulltext (pdf) av Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts
-
Ingår i Molecular Medicine Reports, 2024
- DOI för Reduction of renal activity retention of radiolabeled albumin binding domain-derived affinity proteins using a non-residualizing label strategy compared with a cleavable glycine-leucine-glycine-lysine-linker
- Ladda ner fulltext (pdf) av Reduction of renal activity retention of radiolabeled albumin binding domain-derived affinity proteins using a non-residualizing label strategy compared with a cleavable glycine-leucine-glycine-lysine-linker
-
Ingår i Cancers, 2023
- DOI för Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [Ga-68]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation
- Ladda ner fulltext (pdf) av Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [Ga-68]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation
-
Ingår i Cancers, 2023
- DOI för Phase I Trial of [Tc-99m]Tc-maSSS-PEG(2)-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors
- Ladda ner fulltext (pdf) av Phase I Trial of [Tc-99m]Tc-maSSS-PEG(2)-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors
-
Ingår i International Journal of Molecular Sciences, 2023
- DOI för Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model
- Ladda ner fulltext (pdf) av Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model
-
Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands
Ingår i Pharmaceutics, 2022
- DOI för Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands
- Ladda ner fulltext (pdf) av Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands
-
Ingår i Biomedicines, 2022
- DOI för Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules
- Ladda ner fulltext (pdf) av Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules
-
Ingår i Pharmaceutics, 2022
- DOI för Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT
- Ladda ner fulltext (pdf) av Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT
-
Ingår i Pharmaceutics, 2021
- DOI för Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer
- Ladda ner fulltext (pdf) av Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer
-
Ingår i Pharmaceutics, 2021
- DOI för The Use of a Non-Conventional Long-Lived Gallium Radioisotope 66Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR: 2377 Affibody Molecule
- Ladda ner fulltext (pdf) av The Use of a Non-Conventional Long-Lived Gallium Radioisotope 66Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR: 2377 Affibody Molecule
-
Ingår i Cancers, 2021
- DOI för Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
- Ladda ner fulltext (pdf) av Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
-
Ingår i Cancers, s. 4791-4791, 2021
- DOI för HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers
- Ladda ner fulltext (pdf) av HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers
-
Ingår i Scientific Reports, 2021
- DOI för Ga-66-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [Ga-66]Ga-NOTA-PEG(2)-RM26
- Ladda ner fulltext (pdf) av Ga-66-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [Ga-66]Ga-NOTA-PEG(2)-RM26
-
Ingår i International Journal of Molecular Sciences, 2021
- DOI för Preclinical Evaluation of Tc-99m-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake
- Ladda ner fulltext (pdf) av Preclinical Evaluation of Tc-99m-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake
-
Ingår i Pharmaceutics, 2020
- DOI för Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
- Ladda ner fulltext (pdf) av Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer
-
Ingår i International Journal of Molecular Sciences, 2020
- DOI för Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules
- Ladda ner fulltext (pdf) av Influence of Residualizing Properties of the Radiolabel on Radionuclide Molecular Imaging of HER3 Using Affibody Molecules
-
Ingår i Pharmaceutics, 2020
- DOI för Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model
- Ladda ner fulltext (pdf) av Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model
-
Ingår i Pharmaceutics, 2020
- DOI för Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model.
- Ladda ner fulltext (pdf) av Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model.
-
Ingår i Molecules, 2020
- DOI för Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer
- Ladda ner fulltext (pdf) av Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer
-
Ingår i Molecules, 2020
- DOI för Investigation of a Pharmacological Approach for Reduction of Renal Uptake of Radiolabeled ADAPT Scaffold Protein
- Ladda ner fulltext (pdf) av Investigation of a Pharmacological Approach for Reduction of Renal Uptake of Radiolabeled ADAPT Scaffold Protein
-
On the prevention of kidney uptake of radiolabeled DARPins
Ingår i EJNMMI Research, 2020
- DOI för On the prevention of kidney uptake of radiolabeled DARPins
- Ladda ner fulltext (pdf) av On the prevention of kidney uptake of radiolabeled DARPins
-
Ingår i International Journal of Molecular Sciences, 2020
- DOI för Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules
- Ladda ner fulltext (pdf) av Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules
-
Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
Ingår i International Journal of Molecular Sciences, 2020
- DOI för Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
- Ladda ner fulltext (pdf) av Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
-
Ingår i Cancers, 2019
- DOI för Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug Conjugates
- Ladda ner fulltext (pdf) av Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug Conjugates
-
Ingår i International Journal of Molecular Sciences, 2019
- DOI för Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers
- Ladda ner fulltext (pdf) av Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers
-
Ingår i Scientific Reports, 2019
- DOI för Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111
- Ladda ner fulltext (pdf) av Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111
-
Ingår i Pharmaceutics, 2019
- DOI för Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer
- Ladda ner fulltext (pdf) av Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer
-
Ingår i Scientific Reports, 2019
- DOI för Increase in negative charge of 68Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules
- Ladda ner fulltext (pdf) av Increase in negative charge of 68Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules
-
Ingår i Scientific Reports, 2019
- DOI för Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26
- Ladda ner fulltext (pdf) av Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26
-
Ingår i Scientific Reports, 2019
- DOI för Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake
- Ladda ner fulltext (pdf) av Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake
-
Ingår i International Journal of Molecular Sciences, 2019
- DOI för Indirect Radioiodination of DARPin G3 Using N-succinimidyl-Para-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging
- Ladda ner fulltext (pdf) av Indirect Radioiodination of DARPin G3 Using N-succinimidyl-Para-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging
-
Ingår i International Journal of Oncology, s. 1209-1220, 2019
- DOI för Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2
- Ladda ner fulltext (pdf) av Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2
-
Ingår i Cancers, 2019
- DOI för Bispecific GRPR-antagonistic anti-PSMA/GRPR heterodimer for PET and SPECT diagnostic imaging of prostate cancer
- Ladda ner fulltext (pdf) av Bispecific GRPR-antagonistic anti-PSMA/GRPR heterodimer for PET and SPECT diagnostic imaging of prostate cancer
-
Ingår i International Journal of Cancer, s. 3347-3358, 2019
- DOI för Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu-DOTAGA-PEG2-RM26
- Ladda ner fulltext (pdf) av Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177Lu-DOTAGA-PEG2-RM26
-
Ingår i Molecular Pharmaceutics, s. 3394-3403, 2018
-
Ingår i Cells, 2018
- DOI för Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs
- Ladda ner fulltext (pdf) av Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs
-
Ingår i Theranostics, s. 4462-4476, 2018
- DOI för Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model
- Ladda ner fulltext (pdf) av Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model
-
Ingår i Scientific Reports, 2018
- DOI för Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy
- Ladda ner fulltext (pdf) av Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy
-
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018
-
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018
-
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018
-
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018
-
GRPR-targeted radiotherapy using the Lu-177-labeled GRPR-antagonist DOTAGA-PEG(2)-RM26
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018
-
Ingår i International Journal of Oncology, s. 1765-1774, 2017
- DOI för Evaluation of radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression
- Ladda ner fulltext (pdf) av Evaluation of radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression
-
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017
-
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017
-
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2017
Artiklar, forskningsöversikt
-
PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
Ingår i International Journal of Molecular Sciences, 2021
- DOI för PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
- Ladda ner fulltext (pdf) av PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
Doktorsavhandlingar, sammanläggning
-
Affibody-Based Molecular Imaging and Targeted Therapy of HER3-Expressing Cancer
2022
- Ladda ner fulltext 1 (pdf) av Affibody-Based Molecular Imaging and Targeted Therapy of HER3-Expressing Cancer
- Ladda ner fulltext 2 (pdf) av Affibody-Based Molecular Imaging and Targeted Therapy of HER3-Expressing Cancer